abstract
- These rapid and living practice points from the American College of Physicians address the effectiveness and harms of remdesivir treatment in patients with COVID-19.
Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1)
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
authors
status
publication date
- February 2021
has subject area
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Adenosine Monophosphate (MeSH)
- Alanine (MeSH)
- Antiviral Agents (MeSH)
- COVID-19 Drug Treatment (MeSH)
- Drug Administration Schedule (MeSH)
- Evidence-Based Medicine (MeSH)
- Humans (MeSH)
- SARS-CoV-2 (MeSH)
- Severity of Illness Index (MeSH)
published in
- ACP journal club Journal